B Raf (BRAF) Rabbit Monoclonal Antibody [Clone ID: OTIR1F3]
USD 180.00
2 Weeks*
-
- 30 ul
Product Images
Specifications
Product Data | |
Clone Name | OTIR1F3 |
Applications | WB |
Recommended Dilution | WB1:500 |
Reactivities | Human |
Host | Rabbit |
Isotype | IgG |
Clonality | Monoclonal |
Immunogen | Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human BRAF V600E (NP_004324). The exact sequence is proprietary. |
Formulation | PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. |
Concentration | 1 mg/ml |
Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) |
Conjugation | Unconjugated |
Storage | Shipped at -20°C or with ice packs, Upon delivery store at -20°C. Dilute in PBS(pH7.3) if necessary. Stable for 12 months from date of receipt. Avoid repeated freeze-thaws. |
Gene Name | B-Raf proto-oncogene, serine/threonine kinase |
Database Link | |
Background | This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017] |
Synonyms | B-raf; B-RAF1; BRAF1; NS7; RAFB1 |
Reference Data | |
Protein Families | Druggable Genome, Protein Kinase |
Protein Pathways | Acute myeloid leukemia, Bladder cancer, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Endometrial cancer, ErbB signaling pathway, Focal adhesion, Glioma, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanoma, mTOR signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pancreatic cancer, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Regulation of actin cytoskeleton, Renal cell carcinoma, Thyroid cancer, Vascular smooth muscle contraction |
Documents
Product Manuals |
FAQs |
SDS |
{0} Product Review(s)
Be the first one to submit a review
Product Citations
BRAF mutant(V600E), Myc-DDK-tagged ORF clone of Homo sapiens v-raf murine sarcoma viral oncogene homolog B1 (BRAF) as transfection-ready DNA
-
- 10 ug
Anti-BRAF mouse monoclonal antibody, clone OTI3B12 (formerly 3B12), HRP conjugated
-
- 100 ug
Anti-BRAF mouse monoclonal antibody, clone OTI4C11 (formerly 4C11), HRP conjugated
-
- 100 ug
BRAF mouse monoclonal antibody, clone OTI5A9 (formerly 5A9)
-
- 100 ul
Anti-BRAF mouse monoclonal antibody, clone OTI3C3 (formerly 3C3)
-
- 100 ul
Anti-BRAF mouse monoclonal antibody, clone OTI4C11 (formerly 4C11)
-
- 100 ul
BRAF biotinylated detection antibody, ELISA and Luminex validated mouse monoclonal antibody, clone OTI3A7
-
- 50 ug
BRAF biotinylated detection antibody, ELISA and Luminex validated mouse monoclonal antibody, clone OTI1G8
-
- 50 ug
Anti-BRAF mouse monoclonal antibody, clone OTI4C5 (formerly 4C5)
-
- 100 ul